These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3140070)

  • 1. [Low levels of testosterone in patients with pancreatic carcinoma].
    Militello C; Sperti C; Marra S; Pasquali C; Bonadimani B; Cappellazzo F; Petrin P; Scandellari C; Pedrazzoli S
    Minerva Chir; 1988 Apr; 43(7):581-6. PubMed ID: 3140070
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgen profile in patients with pancreatic carcinoma.
    Sperti C; Bonadimani B; Guolo P; Militello C; Cappellazzo F; Pasquali C; Pedrazzoli S
    Ital J Gastroenterol; 1992; 24(6):328-31. PubMed ID: 1515658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and androgen metabolism in pancreatic cancer.
    Sperti C; Bonadimani B; Militello C; Cappellazzo F; Pedrazzoli S; Guolo P
    J Clin Gastroenterol; 1992 Sep; 15(2):161-2. PubMed ID: 1401831
    [No Abstract]   [Full Text] [Related]  

  • 4. [Usefulness of tissue polypeptide antigen in the diagnosis of pancreatic carcinoma].
    Angonese C; Basso D; Leandro G; Panucci A; Fabris C; Del Favero G; Plebani M; Dodi G; Manghisi OG; Burlina M
    Minerva Dietol Gastroenterol; 1987; 33(2):149-53. PubMed ID: 3627524
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood CA 19-9 in the diagnosis of carcinoma of the pancreas: a critical approach].
    Angonese C; Basso D; Del Favero G; Fabris C; Tremolada C; Plebani M; Burlina A; Naccarato R
    Ann Ital Med Int; 1987; 2(2):138-42. PubMed ID: 3275279
    [No Abstract]   [Full Text] [Related]  

  • 6. [Testosterone-dihydrotestosterone ratio in the differential diagnosis of pancreatic disease].
    Sándor Z; Tulassay Z; Bodrogi L; Papp J; Szathmári M; Fehér T
    Orv Hetil; 1989 Jun; 130(26):1387-8. PubMed ID: 2748159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low serum testosterone: a special feature of hepatocellular carcinoma.
    Lampropoulou-Karatzas C; Goritsas P; Makri MG
    Eur J Med; 1993 Jan; 2(1):23-7. PubMed ID: 8258001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum tissue polypeptide antigen in the differential diagnosis of chronic pancreatitis and exocrine pancreatic tumors. Preliminary results].
    Ruibal A; Encabo G
    Rev Esp Oncol; 1983; 30(3):313-6. PubMed ID: 6571374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human placental and pituitary glycoprotein hormones and their subunits as tumor markers: a quantitative assessment.
    Blackman MR; Weintraub BD; Rosen SW; Kourides IA; Steinwascher K; Gail MH
    J Natl Cancer Inst; 1980 Jul; 65(1):81-93. PubMed ID: 6248674
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of plasma testosterone, carcinoembryonic antigen and CA 19-9 in the differential diagnosis of pancreatic carcinoma and chronic pancreatitis].
    Jurkowska G; Kulpa J; Skrodzka D; Rogowski F
    Pol Arch Med Wewn; 1992 Nov; 88(5):302-9. PubMed ID: 1300550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal predictors of prostate cancer.
    Sofikerim M; Eskicorapci S; Oruç O; Ozen H
    Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of serum testosterone-estradiol-binding globulin, follicular stimulating hormone, luteinizing hormone, estradiol, progesterone, and testosterone levels in women associated with aging].
    Kamatsuki S
    Igaku Kenkyu; 1982 Nov; 52(5):243-55. PubMed ID: 6821181
    [No Abstract]   [Full Text] [Related]  

  • 13. CA 50 compared with CA 19-9 as a serum tumour marker for pancreatic carcinoma.
    Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S
    Ital J Gastroenterol; 1994 May; 26(4):169-73. PubMed ID: 7949259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble interleukin-2 receptor: a new marker in pancreatic adenocarcinoma?
    Rabitti PG; Pacelli L; Uomo G; Laccetti M; Spada OA; Esposito G; Visconti M
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):101-3. PubMed ID: 7948318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low testosterone syndrome in acutely ill adult males.
    Patwardhan MH; Sharma BR; Khanchi RK; Dash RJ
    J Assoc Physicians India; 1986 May; 34(5):343-5. PubMed ID: 3093458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ca 19-9 antigen in differentiation of pancreatic inflammatory and neoplastic tumors].
    Markocka-Maczka K
    Wiad Lek; 2003; 56(11-12):537-40. PubMed ID: 15058160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prostate-specific antigen in pancreatic disease.
    Pezzilli R; Bertaccini A; Billi P; Zanarini L; Miglio F; Martorana G
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):580-3. PubMed ID: 10604096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating plasma levels of follicle-stimulating hormone, luteinizing hormone and testosterone in malnourished male children.
    Nduka EU; Dada OA; Johnson AO; Agbedana EO
    Turk J Pediatr; 1987; 29(3):151-4. PubMed ID: 3146826
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood hormone levels in persons of various blood groups].
    Iakovlev GM; Kulagin KV
    Voen Med Zh; 1985 Apr; (4):74-6. PubMed ID: 2990105
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormonal profile in inflammatory and neoplastic processes in the larynx].
    Pogosov VS; Kasatkin IuN; Shadyev KhD; Ametov AS; Smirnova LK
    Zh Ushn Nos Gorl Bolezn; 1977; (1):16-8. PubMed ID: 868252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.